Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly...
The Biden administration's plan to reclassify cannabis as a Schedule III substance through the Drug Enforcement Administration (DEA) could have...
TESTSTSARDSAR Cannabis Industry Reacts to DEA Rescheduling by Cannabis & Tech Today In a long-awaited announcement, the Drug Enforcement Agency...
Cannara Biotech Inc. (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0) announced its fiscal second quarter 2024 financial and operating results for the three...
IM Cannabis Corp. (NASDAQ:IMCC) shares are trading higher Wednesday, and the stock is up more than 100% over the past...
In a swift, almost frenzied surge, cannabis stocks soared following Tuesday's news that the DEA intends to begin the process...
Cannabis stocks Canopy Growth Corporation (NASDAQ:CGC), Aurora Cannabis, Inc. (NASDAQ:ACB) and Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading lower Wednesday...
Medical Marijuana 411 (MM411), a provider of digital cannabis education, has partnered with CReDO Science, helmed by the renowned Dr....
Talarya Brands, a pioneering leader in the cannabis industry, today highlighted record-breaking financial and operational performance following the recent Drug...
Tim Seymour, founder and chief investment officer of Seymour Asset Management, provided profound insights at the recent Benzinga Cannabis Capital...